Sinopharm Tech Holdings Limited (8156.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 85.99M |
| Enterprise Value | 125.77M |
| P/E Ratio | 22.03 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 1.14 |
| Price/Book Ratio | -2.51 |
| Enterprise/Revenue | 1.38 |
| Enterprise/EBITDA | 42.83 |
Fiscal Year
| Fiscal Year | June 30, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.04 |
| Operating Margin | -0.07 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | -0.08 |
Income Statement
| Revenue | 61.25M |
| Revenue/Share | 0.14 |
| Gross Profit | 13.52M |
| EBITDA | 6.11M |
| Net Income | -867,000 |
| Diluted EPS | -0 |
Balance Sheet
| Total Cash | 12.88M |
| Total Cash/Share | 0.02 |
| Total Debt | 34.55M |
| Total Debt/Equity | -0.84 |
| Current Ratio | 0.66 |
| Book Value Per Share | -0.06 |
Price History
| 52-Week Change | -50.61 |
| 52-Week High | 0.37 |
| 52-Week Low | 0.16 |
| Moving Average 50 Days | 0.2 |
| Moving Average 200 Days | 0.27 |
Statistics
| Average Volume | 21,883 |
| Shares Outstanding | 633.69M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | August 29, 2023 |
AD
